TIRZEPATIDE

Tirzepatide is a synthetic peptide that selectively activates glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. It has been studied for its effects on blood-glucose regulation, appetite, body weight and metabolic function.

Studied Uses
Tirzepatide has been clinically studied in areas including:

Type 2 diabetes and glycaemic control
Obesity and long-term weight management
Appetite and food-intake regulation
Body-weight and body-composition changes
Insulin secretion and insulin sensitivity
Moderate-to-severe obstructive sleep apnea in adults with obesity
Authorized tirzepatide formulations have indications for improving glycaemic control in people with type 2 diabetes, reducing and maintaining body weight in qualifying adults, and treating moderate-to-severe obstructive sleep apnea in adults with obesity.

How It Works
Tirzepatide binds to and activates both GIP and GLP-1 receptors. These hormone pathways help regulate insulin secretion, glucagon activity, appetite and food intake.

When blood glucose is elevated, tirzepatide enhances insulin secretion and reduces glucagon levels in a glucose-dependent manner. It also influences appetite-regulating areas of the brain, decreases food intake and delays gastric emptying.

Product Details
Product: Tirzepatide
Strength: 10 mg
Form: Lyophilized powder
Presentation: Single vial